Welcome to the Cytrellis News Center. Here you can explore the latest news and information about the company, upcoming events and recent publications.

The New Non-Surgical Facelift: Can Dermal Micro-Coring Come Close to Surgery?

Despite the immeasurable rise of machines and injectables over the last 20 years, one could argue that a weak spot still exists in the non-surgical armamentarium: a truly powerful way to lift and tighten the skin…
Read More

The Next 25 Years in Beauty

As seen in Marie Claire

“In 2 years, you won’t need surgery to give your face a lift”… The Cytrellis treatment “is like a facelift by a thousand small cuts instead of a few big ones, but there’s no scarring and the results are subtler,” says Dr. Mathew Avram, faculty director of the Dermatology Laser and Cosmetic Center at Massachusetts General Hospital. “Trials are underway now.”

Read More

Cytrellis Completes $28.5 Million Series B Financing

Cytrellis announced today that it has received $28.5 million in a Series B round which included existing investors ARCH Venture Partners, the Merz Venture Initiative and new investors, Partner Fund Management and Biomatics Captial.

Read More

Cytrellis Clinical Results Recently Presented at 2018 ASLMS Conference

Dr. Roy Geronemus, director of the Laser & Skin Surgery Center of New York, recently presented findings from Cytrellis’ multi-center study of 23 women who were treated bilaterally in the mid and lower face, using Cytrellis’ proprietary device.

Read More

Merz Pharma announces new investment in Cytrellis Biosystems

Merz Pharma has made a strategic investment in Cytrellis Biosystems, a US based company developing a new class of non-surgical products to combat sagging skin associated with aging.

Read More

Cytrellis now on Facebook

Check out our new Facebook page at Please like us to get the latest news on Cytrellis.

Read More